BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33530154)

  • 1. Association between maternal human immunodeficiency virus infection and preterm birth: A matched case-control study from a pregnancy outcome registry.
    Elenga N; Djossou FÉL; Nacher M
    Medicine (Baltimore); 2021 Jan; 100(4):e22670. PubMed ID: 33530154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.
    Patel K; Shapiro DE; Brogly SB; Livingston EG; Stek AM; Bardeguez AD; Tuomala RE;
    J Infect Dis; 2010 Apr; 201(7):1035-44. PubMed ID: 20196654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysis.
    Mesfin YM; Kibret KT; Taye A
    Reprod Health; 2016 Apr; 13():30. PubMed ID: 27048501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination antiretroviral use and preterm birth.
    Watts DH; Williams PL; Kacanek D; Griner R; Rich K; Hazra R; Mofenson LM; Mendez HA;
    J Infect Dis; 2013 Feb; 207(4):612-21. PubMed ID: 23204173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.
    Powis KM; Kitch D; Ogwu A; Hughes MD; Lockman S; Leidner J; van Widenfelt E; Moffat C; Moyo S; Makhema J; Essex M; Shapiro RL
    J Infect Dis; 2011 Aug; 204(4):506-14. PubMed ID: 21791651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    Venkatesh KK; Farhad M; Fenton T; Moodley D; Naik S; Nakabiito C; Fairlie L; Fowler MG; Stringer JSA; Chi BH
    AIDS; 2019 Dec; 33(15):2403-2413. PubMed ID: 31764105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.
    Koss CA; Natureeba P; Plenty A; Luwedde F; Mwesigwa J; Ades V; Charlebois ED; Clark TD; Achan J; Ruel T; Nzarubara B; Kamya MR; Havlir DV; Cohan D
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):128-35. PubMed ID: 25072616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women.
    Malaba TR; Phillips T; Le Roux S; Brittain K; Zerbe A; Petro G; Ronan A; McIntyre JA; Abrams EJ; Myer L
    Int J Epidemiol; 2017 Oct; 46(5):1678-1689. PubMed ID: 29040569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
    Azria E; Moutafoff C; Schmitz T; Le Meaux JP; Krivine A; Pannier E; Firtion G; Compagnucci A; Finkielsztejn L; Taulera O; Tsatsaris V; Cabrol D; Launay O
    Antivir Ther; 2009; 14(3):423-32. PubMed ID: 19474476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitors and preterm delivery: another piece in the puzzle.
    Favarato G; Townsend CL; Bailey H; Peters H; Tookey PA; Taylor GP; Thorne C
    AIDS; 2018 Jan; 32(2):243-252. PubMed ID: 29135577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
    Rough K; Seage GR; Williams PL; Hernandez-Diaz S; Huo Y; Chadwick EG; Currier JS; Hoffman RM; Barr E; Shapiro DE; Patel K;
    N Engl J Med; 2018 Apr; 378(17):1593-1603. PubMed ID: 29694825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Tuomala RE; Shapiro DE; Mofenson LM; Bryson Y; Culnane M; Hughes MD; O'Sullivan MJ; Scott G; Stek AM; Wara D; Bulterys M
    N Engl J Med; 2002 Jun; 346(24):1863-70. PubMed ID: 12063370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?
    Cotter AM; Garcia AG; Duthely ML; Luke B; O'Sullivan MJ
    J Infect Dis; 2006 May; 193(9):1195-201. PubMed ID: 16586354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat Pregnancies Among US Women Living With HIV in the SMARTT Study: Temporal Changes in HIV Disease Status and Predictors of Preterm Birth.
    O'Brien BE; Williams PL; Huo Y; Kacanek D; Chadwick EG; Powis KM; Correia K; Haddad LB; Yee LM; Chakhtoura N; Dola C; Van Dyke RB;
    J Acquir Immune Defic Syndr; 2020 Nov; 85(3):346-354. PubMed ID: 32701825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.